The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development

Journal of Experimental Medicine

Volumn 208, Issue 11, 2011, Pages 2183-2191

  Colacios, Céline ^a,b,c   Casemayou, Audrey ^a,b,c   Dejean, Anne S ^a,b,c   Gaits Iacovoni, Frédérique ^a   Pedros, Christophe ^a,b,c   Bernard, Isabelle ^a,b,c   Lagrange, Dominique ^a,b,c   Deckert, Marcel ^a   Lamouroux, Lucille ^a,b,c   Jagodic, Maja ^d   Olsson, Tomas ^d   Liblau, Roland S ^a,b,c   Fournié, Gilbert J ^a,b,c   Saoudi, Abdelhadi ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c France   (France)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL MATURATION; CHROMOSOME 9; CHROMOSOME MAP; CONGENIC STRAIN; GENE; GENE ACTIVATION; GENE FUNCTION; GENE LOCUS; INTRACELLULAR SIGNALING; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; THYMUS; VAV1 GENE;

ANIMALS; ANIMALS, CONGENIC; ARGININE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHROMOSOMES, MAMMALIAN; FORKHEAD TRANSCRIPTION FACTORS; HEK293 CELLS; HUMANS; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-VAV; RATS; RATS, INBRED LEW; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CHIMERA; TRYPTOPHAN;

EID: 80055119138     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20102191     Document Type: Article

References (30)

1. Aghazadeh, B., W.E. Lowry, X.Y. Huang, and M.K. Rosen. 2000. Structural basis for relief of autoinhibition of the Dbl homology domain of protooncogene Vav by tyrosine phosphorylation. Cell. 102:625-633. http://dx.doi.org/10.1016/S0092-8674(00)00085-4
2. Alper, C.A., A.M. Johnson, A.G. Birtch, and F.D. Moore. 1969. Human C'3: evidence for the liver as the primary site of synthesis. Science. 163:286-288. http://dx.doi.org/10.1126/science.163.3864.286
3. Cabarrocas, J., C. Cassan, F. Magnusson, E. Piaggio, L. Mars, J. Derbinski, B. Kyewski, D.A. Gross, B.L. Salomon, K. Khazaie, et al. 2006. Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc. Natl. Acad. Sci. USA. 103:8453-8458. http://dx.doi.org/10.1073/pnas.0603086103
4. Carter, J.D., G.M. Calabrese, M. Naganuma, and U. Lorenz. 2005. Deficiency of the Src homology region 2 domain-containing phosphatase 1 (SHP-1) causes enrichment of CD4+CD25+ regulatory T cells. J. Immunol. 174: 6627-6638.
5. Cautain, B., J. Damoiseaux, I. Bernard, H. van Straaten, P. van Breda Vriesman, B. Boneu, P. Druet, and A. Saoudi. 2001. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 31:1132-1140. http://dx.doi.org/10.1002/1521-4141(200104)31:4<1132::AID-IMMU1132>3.0 .CO;2-N
6. Deckert, M., S. Tartare-Deckert, C. Couture, T. Mustelin, and A. Altman. 1996. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity. 5:591-604. http://dx.doi.org/10.1016/S1074-7613(00)80273-3
7. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. http://dx.doi.org/10.1016/j.immuni.2005.01.016
8. Fournié, G.J., B. Cautain, E. Xystrakis, J. Damoiseaux, M. Mas, D. Lagrange, I. Bernard, J.-F. Subra, L. Pelletier, P. Druet, and A. Saoudi. 2001. Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases. Immunol. Rev. 184:145-160. http://dx.doi.org/10.1034/j.1600-065x.2001.1840114.x
9. García-Mata, R., K. Wennerberg, W.T. Arthur, N.K. Noren, S.M. Ellerbroek, and K. Burridge. 2006. Analysis of activated GAPs and GEFs in cell lysates. Methods Enzymol. 406:425-437. http://dx.doi.org/10.1016/S0076-6879(06)06031-9
10. Gupta, S., S. Manicassamy, C. Vasu, A. Kumar, W. Shang, and Z. Sun. 2008. Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol. Immunol. 46:213-224. http://dx.doi.org/10.1016/j.molimm.2008.08.275
11. Hsieh, C.S., Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. Rudensky. 2004. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity. 21:267-277. http://dx.doi.org/10.1016/j.immuni.2004.07.009
12. Jagodic, M., C. Colacios, R. Nohra, A.S. Dejean, A.D. Beyeen, M. Khademi, A. Casemayou, L. Lamouroux, C. Duthoit, O. Papapietro, et al. 2009. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci. Transl. Med. 1:10ra21. http://dx.doi.org/10.1126/scitranslmed.3000278
13. Jordan, M.S., A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, M.A. Lerman, A. Naji, and A.J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-306. http://dx.doi.org/10.1038/86302
14. Josefowicz, S.Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity. 30:616-625. http://dx.doi.org/10.1016/j.immuni.2009.04.009
15. Katzav, S., D. Martin-Zanca, and M. Barbacid. 1989. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283-2290.
16. Koonpaew, S., S. Shen, L. Flowers, and W. Zhang. 2006. LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J. Exp. Med. 203:119-129. http://dx.doi.org/10.1084/jem.20050903
17. López-Lago, M., H. Lee, C. Cruz, N. Movilla, and X.R. Bustelo. 2000. Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol. Cell. Biol. 20:1678-1691. http://dx.doi.org/10.1128/MCB.20.5.1678-1691.2000
18. Mas, M., P. Cavaillès, C. Colacios, J.F. Subra, D. Lagrange, M. Calise, M.O. Christen, P. Druet, L. Pelletier, D. Gauguier, and G.J. Fournié. 2004. Studies of congenic lines in the Brown Norway rat model of Th2-mediated immunopathological disorders show that the aurothiopropanol sulfonate-induced immunological disorder (Aiid3) locus on chromosome 9 plays a major role compared to Aiid2 on chromosome 10. J. Immunol. 172:6354-6361.
19. Medoff, B.D., B.P. Sandall, A. Landry, K. Nagahama, A. Mizoguchi, A.D. Luster, and R.J. Xavier. 2009. Differential requirement for CARMA1 in agonistselected T-cell development. Eur. J. Immunol. 39:78-84. http://dx.doi.org/10.1002/eji.200838734
20. Miletic, A.V., D.B. Graham, K. Sakata-Sogawa, M. Hiroshima, M.J. Hamann, S. Cemerski, T. Kloeppel, D.D. Billadeau, O. Kanagawa, M. Tokunaga, and W. Swat. 2009. Vav links the T cell antigen receptor to the actin cytoskeleton and T cell activation independently of intrinsic Guanine nucleotide exchange activity. PLoS ONE. 4:e6599. http://dx.doi.org/10.1371/journal.pone.0006599
21. Ouyang, W., O. Beckett, Q. Ma, J.H. Paik, R.A. DePinho, and M.O. Li. 2010. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11:618-627. http://dx.doi.org/10.1038/ni.1884
22. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell. 133:775-787. http://dx.doi.org/10.1016/j.cell.2008.05.009
23. Saveliev, A., L. Vanes, O. Ksionda, J. Rapley, S.J. Smerdon, K. Rittinger, and V.L. Tybulewicz. 2009. Function of the nucleotide exchange activity of vav1 in T cell development and activation. Sci. Signal. 2:ra83. http://dx.doi.org/10.1126/scisignal.2000420
24. Subra, J.F., B. Cautain, E. Xystrakis, M. Mas, D. Lagrange, H. van der Heijden, M.J. van de Gaar, P. Druet, G.J. Fournié, A. Saoudi, and J. Damoiseaux. 2001. The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled. J. Immunol. 166:2944-2952.
25. Turner, M., and D.D. Billadeau. 2002. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat. Rev. Immunol. 2:476-486. http://dx.doi.org/10.1038/nri840
26. Tybulewicz, V.L. 2005. Vav-family proteins in T-cell signalling. Curr. Opin. Immunol. 17:267-274. http://dx.doi.org/10.1016/j.coi.2005.04.003
27. van Santen, H.M., C. Benoist, and D. Mathis. 2004. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200:1221-1230. http://dx.doi.org/10.1084/jem.20041022
28. Wan, Y.Y., H. Chi, M. Xie, M.D. Schneider, and R.A. Flavell. 2006. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7:851-858. http://dx.doi.org/10.1038/ni1355
29. Yu, B., I.R. Martins, P. Li, G.K. Amarasinghe, J. Umetani, M.E. Fernandez-Zapico, D.D. Billadeau, M. Machius, D.R. Tomchick, and M.K. Rosen. 2010. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 140:246-256. http://dx.doi.org/10.1016/j.cell.2009.12.033
30. Zheng, Y., and A.Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8:457-462. http://dx.doi.org/10.1038/ni1455